Learn more

DELTAGEN INC

Overview
  • Total Patents
    153
About

DELTAGEN INC has a total of 153 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology, agriculture and pharmaceuticals are ALLEN KEITH D, PHARMACEUTICAL PROTEINS LTD and BRENNAN THOMAS J.

Patent filings per year

Chart showing DELTAGEN INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Allen Keith D 79
#2 Leviten Michael W 36
#3 Brennan Thomas J 29
#4 Moore Mark 27
#5 Matthews William 23
#6 Guenther Catherine 19
#7 Phillips Russell 16
#8 Klein Robert 14
#9 Wisotzkey Robert G 11
#10 Kirk Christopher J 10

Latest patents

Publication Filing date Title
US2006037094A1 Secreted protein associated with depression, compositions and methods of use thereof
US7176346B1 SLC19A2 amino acid transporter gene disruptions, and compositions and methods related thereto
AU2002331900A1 Carboxypeptidase n (cpn) disruptions compositions and methods relating thereto
WO03081997A1 CALPAIN LARGE SUBUNIT (n-CL4) CYSTEINE PROTEASE GENE DISRUPTIONS, AND COMPOSITIONS AND METHODS RELATED THERETO
AU2002327731A1 Ccr6 chemokine receptor disruptions, compositions and methods relating thereto
AU2002341826A1 Gng4 gene disruptions, compositions and methods related thereto
AU2002341825A1 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
AU2002341824A1 Thyrotropin releasing hormone receptor disruptions, compositions and methods relating thereto
AU2002340001A1 Metabotropic glutamate receptor 4b (mglur4) disruptions, compositions and methods relating thereto
WO03026395A2 Mo54 gene disruptions, compositions and methods related thereto
AU2002340000A1 Cathepsin g (ctsg) disruptions, compositions and methods relating thereto
AU2002334661A1 Transgenic mice containing socs-5 cytokine signalling suppressor gene disruptions
WO03026407A1 Glycerol kinase gene disruptions, compositions and methods related thereto
WO03026403A2 Ctsz disruptions, compositions and methods relating thereto
AU2002312592A1 Protein tyrosine phosphatase 2 gene disruptions, compositions and methods related thereto
US7164055B2 HSPC150-like gene disruptions, compositions and methods related thereto
AU2002352179A1 Putative neurotransmitter receptor (pnr) disruptions, compositions and methods relating thereto
WO03001883A2 Gaba b1a receptor disruptions, compositions and methods relating thereto
WO03001907A1 Nmp35 apoptosis inhibitor gene disruptions compositions and methods related thereto
AU2002318429A1 Usp-3like deubiquitinating enzyme gene disruptions, compositions and methods related thereto